With over three decades of experience, Dr Gunn has held pivotal roles in leading biotech firms and academic institutions including Pfizer, Crucell (Johnson & Johnson), Becton Dickson, Clintec (IQVIA), ICON, and Health Decisions (Premier Research). She is a corporate strategy expert with extensive experience in life science corporate development, strategic partnerships, co-development, licensing partnerships, M&A and post-merger integrations. She is renowned for her extensive contributions to medical research, innovative drug development, contract research and clinical trials, and has spearheaded the development of several FDA-approved drugs, particularly in the CNS and vaccines domains. She is passionate about market access to innovation.
Matthew is the Chief Financial Officer for George Clinical. He was formerly the Chief Financial Officer for global IVF service provider Virtus Health and prior to this, Vice President, Finance & Commercial Operations, Asia Pacific for Cochlear. He previously served as the Head of Equities Research at Evans & Partners and Head of Healthcare Equities Research, Asia for Bank of America where he analyzed the healthcare companies across Asia and was involved in numerous listed market transactions. Matthew also worked as a Research Analyst at Merrill Lynch and Deutsche Bank and started his career in accounting at Deloitte and Ernst & Young in Australia. He is based in the Australian offices of George Clinical.
As the Chief Commercial Officer, Michael leads the US, Europe, and APAC business development teams, along with proposal and contracting groups. He brings over 30 years of business development and life sciences experience with companies including Cardinal Health, PPD, ICON, and, most recently, Ergomed/PrimeVigilance. Over the last 16+ years, Michael has led various CRO commercial teams including those in business development and global strategic accounts driving business strategy for large pharma and biotech companies. He also has a strong background in supporting strategic partnerships, proposal development, inside sales, and sales training and development.
Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she led the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. Maria has worked closely with the scientific leads at the George Institute to develop and implement scientific leadership models for George Clinical studies, as well as to develop new ideas for clinical research, and processes to improve clinical trial design and efficiencies. Maria has several years’ experience in both public health and clinical research as well as research management across a range of settings including hospitals, academic and clinical research organizations.
Jing Ping oversees operational delivery for studies conducted globally and heads the project operations group. She also provides oversight to key accounts at governance levels. With almost three decades of leadership and management experience, she has overseen all aspects of a startup’s operations in Asia Pacific and led a global biopharmaceutical unit with multi-compound, multi-therapeutic portfolios. Her research expertise spans budgetary management, clinical drug development, clinical operations, project management, biometrics, medical writing, medical affairs and quality management. Currently, she serves as the Steering Committee Member for the of Drug Information Association (DIA), is the Program Committee for DIA-Asia and chairs the Singapore Clinical Research Professionals Association.
As Country Head, China, Zhenfei is responsible for leading the operations teams across China. Zhenfei Yin brings with him more than 17 years of substantial industry experience leading Project Management, Clinical Operations, and Business Development teams across the CRO and Pharmaceutical sectors. Before joining George Clinical as China country head, he worked in several global CROs and pharmaceuticals, including ICON, Wuxi AppTec, IQVIA, and Sanofi. His successfully led team completed more than 120 Phase I – IV clinical trials, most of which are global studies (Asia Pacific, Australia and the United States), covering different Therapeutic Area, including: Oncology, Cardiovascular, Central nervous system, Endocrine, Infectious diseases, Urology, Respiratory diseases, and medical devices/IVDs. He has Master Degree of Urology from Peking University 1st Hospital.
Abby Abraham serves as the Global Head of Data Science for George Clinical. Abby is responsible for developing new capabilities in data science and operations and enabling continued growth of Data management in the organization. He brings a combination of significant experience in clinical operations, leveraging data for operational effectiveness, and adopting new technologies to enable the organizational transition to new and emerging paradigms of clinical trial execution. His experience in business operations, strategy, and new technology adoption enable George Clinical to pursue innovation-led growth. In addition to his responsibilities in Data Science, he is also the Country Head of India business operations.
Louise Brnabic, Global Head, Quality, and is responsible for providing quality management support for all functional areas and countries, ensuring that global standards are maintained in all clinical trial-related activities. With a background in biochemical research, Louise has 20 years’ experience in quality management, project management, and clinical operations. She has worked with pharmaceutical and device companies, across all study phases and in a wide range of therapeutic areas.
Harmony leads the Human Resources (HR) team globally to effectively partner with the organization to deliver on its people and company objectives. Harmony has over 15 years of talent acquisition and generalist HR experience across the Life Sciences, IT&T and Built Environment industries globally and is MBA qualified in addition to holding a BA (Organizational Learning) and being Training & Assessment certified.
